Confidential inquiries into maternal deaths in the UK were established in 1952 and have aimed to report on every pregnancy related death since then Maternal deaths from hypertensive disorders of pregnancy have reduced dramatically in the UK over the past 60 years Incremental improvement in clinical management and organisation of care through recommendations made in the confidential inquiry reports and publication of national guidelines are likely to have driven much of this decline in recent decades To tackle global maternal mortality related to hypertensive disorders, setting up a confidential inquiry is an important first step for many countries Almost complete eradication of maternal mortality related to hypertensive disorders of pregnancy seems possible Maternal deaths in the United Kingdom have been the subject of confidential inquiries since 1952. In this time, deaths from hypertensive disorders of pregnancy have substantially reduced in both absolute and relative terms, from 200 women in a three year period in England and Wales (1952-54), to three women across the whole of the UK in the most recent report .
Incremental improvement in clinical management and organisation of care through recommendations made in the confidential inquiry reports and publication of national guidelines are likely to have driven much of this decline in recent decades
To tackle global maternal mortality related to hypertensive disorders, setting up a confidential inquiry is an important first step for many countries Almost complete eradication of maternal mortality related to hypertensive disorders of pregnancy seems possible Maternal deaths in the United Kingdom have been the subject of confidential inquiries since 1952. In this time, deaths from hypertensive disorders of pregnancy have substantially reduced in both absolute and relative terms, from 200 women in a three year period in England and Wales (1952-54) , to three women across the whole of the UK in the most recent report . 1 Deaths from hypertensive disorders are also falling globally, but not as dramatically as in the UK.
2 Pre-eclampsia and eclampsia are still estimated to cause approximately 30 000 maternal deaths annually worldwide, mostly in low and middle income countries.
3 4 As with any death, maternal deaths have a huge impact on families, particularly as they are usually unexpected in young adults and involve a child (box 1).
Box 1: Experiencing pre-eclampsia
"Losing anyone is hard at any time but losing your partner when you are on the cusp of becoming a family is the most devastating thing that can happen to a dad. From planning on being a family to being alone tears you up; it happened so suddenly, I went from joy and excitement to devastation just hours later. This changed the path of my life forever and the lack of care for grieving partners is abysmal"-man who lost his partner and daughter in 2016 "When you have an arm or leg amputated you can get a prosthetic limb, when your sweetheart is taken from you there is no prosthetic for an amputated soul. I tell my son the brightest twinkling star is his mum opening a curtain in heaven and checking up on us, and his freckles are angel kisses from when his Mum visits him when he's fast asleep. There will never be a Champagne moment in this process, no one can give me back my wife"-man who lost his wife in 2006
For women sharing their experiences of pre-eclampsia, see http://healthtalk. org/pre-eclampsia Over the past 65 years, UK confidential inquiries have assessed the causes of maternal deaths, searched for avoidable factors, and aimed to reduce maternal morbidity and mortality by providing recommendations for clinical care, service organisation, and research priorities. Identifying the factors involved in the fall in maternal deaths from hypertensive disorders in the UK may help other health systems to reduce their maternal death rates.
We reviewed and analysed the original confidential inquiry reports, providing aggregated triennial data, from the earliest (England and Wales, 1952-54) to the latest (UK, 2013-15) . Definitions of maternal deaths and hypertensive disorders used in these reports are listed in supplementary table 1.
The changing picture of maternal deaths from hypertensive disorders
Since the first confidential inquiry into maternal deaths the number of maternities has fluctuated but, on the whole, remained stable over time (fig 1) , allowing for the change in data collection from England and Wales to the whole of the UK. By contrast, the maternal death rate from hypertensive disorders of pregnancy has shown a strong downward trend, from 9.74 maternal deaths per 100 000 maternities in the first confidential enquiry , to 0.09 per 100 000 in the 2012-14 report. This trend is most dramatic in recent years and in the first 15 years of the inquiries and has been sustained despite a broadly similar denominator throughout.
Deaths from hypertensive disorders accounted for a fairly stable proportion (11-20.5%) of direct maternal deaths (deaths resulting from obstetric complications of the pregnant state) until 2012-14, when they fell to only 4.5% of direct deaths (fig 2) and 1.5% of all maternal deaths (direct and indirect causes).
These figures can be broken down to examine the cause of death in detail-cerebral, hepatic, miscellaneous, pulmonary, or renal)-which were first included in the report from 1958-60 (fig 3) (supplementary table 2A and 2B) . Before this, deaths related to hypertensive disorders were ascribed to pre-eclampsia (21.8%) or eclampsia (24.7%) only, reflecting less detailed information available to the inquiry.
Over the 65 years of inquiries, intracranial haemorrhage was the single most common specified cause of death, responsible for 226 of 1063 maternal hypertensive deaths (21.7%). Other common causes of death include renal failure, particularly in earlier reports (6.4%); hepatic causes, including hepatic failure or necrosis (5.6%); and pulmonary complications, including acute respiratory distress syndrome (3.5%) and pulmonary oedema (1.1%), which was last reported in 1994-96. Cardiac failure and anaesthetic complications were responsible for 1.4% and 1.2% of deaths over the 65 year period, but no deaths have been reported since the 1980s.
What has driven the reduction in deaths?
The confidential inquiry reports identify areas for improvement and make recommendations for clinical care of women with hypertensive disorders of pregnancy (supplementary table 3 ). The rate of decline in mortality from hypertensive disorders was most rapid between the 1950s and 1970s. Although we cannot draw causal inferences from the trends noted in this analysis, it is possible-and has been suggested elsewhere 5 -that this rapid rate of decline was due to wider provision and improved quality of antenatal care with the founding of the NHS in 1948, leading to earlier detection of hypertension and appropriate referral to hospital care. Poor antenatal care was mentioned in early confidential reports as the most frequent avoidable factor in maternal deaths. Other findings were poor education provisions for pregnant women and challenges in organisation of care, particularly difficulties in communication between community and hospital (supplementary table 3)  (supplementary table 4 ).
Nutrition also improved in the post-war period, with introduction of the national milk and vitamin schemes for pregnant women in the 1940s. 6 Improved consumption of calcium in populations where calcium intake is low has been shown to reduce the incidence of hypertension in pregnancy, 7 although lack of reliable trend data on the incidence of pregnancy hypertensive disorders in the UK precludes further analysis. Other sociological factors may also have contributed to the trend, particularly improved access to all kinds of healthcare after the introduction of the NHS and an increase in babies being delivered in hospital (rather than at home), from 63.7% in 1954 to 91.4% in 1972. 8 The decline in maternal mortality between the 1970s and the millennium is likely to have been achieved by improvements in organisation of care and clinical management of hypertensive disorders of pregnancy. Important inquiry recommendations from this period included senior staff involvement (supplementary table 4), prompt treatment of systolic hypertension, raising awareness of fluid overload and the need for strict fluid balance, and implementation of evidence showing superiority of magnesium sulfate in eclampsia management (supplementary table 5).
Cerebral haemorrhage was reported as the most common cause of death for the first time in the mid-1970s, with recommendations made to control blood pressure soon thereafter (supplementary table 3; supplementary table 5 ). The 1985-87 inquiry reported a death from acute respiratory distress syndrome for the first time and noted the dangers of fluid overload, with deaths from pulmonary oedema. It also criticised the use of diazepam for prevention of eclamptic seizures and advised the scientific re-evaluation of magnesium sulfate and phenytoin for the management of eclampsia. The recommendation to have clear protocols for hypertensive disorders of pregnancy was first made in the 1988-90 report. After the Eclampsia Collaborative Trial was published, 9 magnesium sulfate for eclampsia management was recommended in the 1991-93 report (published in 1996) , alongside strict fluid balance in women with pre-eclampsia and eclampsia. Notably, the last recorded death from pulmonary oedema associated with hypertensive disorders of pregnancy in the UK was in 1994-96.
In 1985-87 the main factors requiring improvement were human factors, with inappropriate delegation of care to junior staff and communication delays being key concerns. Recommendations for early involvement of senior staff and the development of expert regional teams to provide support to non-specialist units were made (supplementary table 4) .
By the millennium, maternal deaths from hypertensive disorders had substantially reduced, having been less than 1 death per 100 000 maternities for almost a decade. Renal, hepatic, and pulmonary causes of death had all decreased, leaving cerebral causes of death, primarily due to intracranial haemorrhage, remaining. This led to a primary focus on the need to treat hypertension effectively, the key message from the 2000-02 report onwards (supplementary table 3 fig 4; supplementary  table 5) The 2003-05 report recommended a treatment threshold of 160 mm Hg systolic blood pressure for starting antihypertensives, which was subsequently reduced to 150 mm Hg (2006-08) . The latter report also noted that the incidence of eclampsia had halved, probably due to widespread use of magnesium sulfate.
Recommendations of the confidential inquiries have been incorporated into specific evidence based guidelines, such as the first version of the National Institute for Health and Care Excellence (NICE) Guideline for management of hypertension in pregnancy published in 2010. 10 This guideline advised screening and prevention of pre-eclampsia with aspirin, lowering of blood pressure targets, and planned delivery at 37 weeks' gestation for women with pre-eclampsia. These national guidelines have promoted universal provision of standardised care, rather than management by individual clinician preference, and are likely to have driven the notable recent reduction in deaths. Alongside this, direct involvement of patient support groups in the production of lay summaries of the confidential inquiry reports has empowered women to seek this standardised high quality care.
Intracranial haemorrhage remains the most common specific cause of death from hypertensive disorders of pregnancy overall. Inadequately treated hypertension is likely to be the most important aetiological factor in intracranial haemorrhage, so the monitoring and control of blood pressure through use of clear blood pressure targets for hypertensive pregnant women is likely to remain of pivotal importance.
Comparison with other countries
The UK confidential inquiries show the powerful process of data collation generating research questions guided by clinical need, these research findings being translated into evidence based national guidelines and reports, and the resultant engagement of healthcare workers and influence on clinical practice leading to improved outcomes. This model is particularly relevant to outcomes such as maternal deaths, which are less common in high income settings and are otherwise difficult to study.
Since their inception in the UK, confidential enquiries into maternal deaths have been set up in numerous other countries. The South African inquiries, running since 1997, show that maternal deaths from hypertensive disorders have decreased overall between 2002-04 and 2011-13, but remain one of the top five causes of maternal deaths, responsible for 14.8% of deaths in 2011-13. 11 Similar to the UK, cerebral complications are the most common cause of death (58.2%), related to failure to control severe hypertension. The latest report recommends aggressive control of hypertension, reinforcing the South African Maternity Guidelines, which implies that guideline implementation is an important focus in the South African setting. Teenagers and women under 25 who are pregnant for the first time are also at higher risk of death from pre-eclampsia, so reproductive services are being targeted at this group.
11
In a recent review of maternal deaths in Norway from 1996 to 2014, hypertensive disorders were the most frequent cause of maternal deaths, and in 14 of 16 cases assessors concluded that better care may have improved the outcome.
12 Pulmonary oedema was the most common cause of death (43.8%), followed by intracranial haemorrhage (37.5%). The authors point to the lack of recommendations on timing of delivery in women with hypertensive disorders and treatment thresholds for diastolic (rather than systolic) blood pressure in the Norwegian obstetric guidelines at the time of the study. They recommend implementation of evidence based guidelines (similar to those implemented in the UK in 2010) with clear systolic treatment thresholds for hypertension drugs and guidance on fluid management and timing of delivery.
12
France, which has had confidential inquiries since 1996, has also achieved a substantial reduction in maternal deaths from hypertensive disorders-the rate halved from 1 per 100 000 live births in 2007-09 to 0.5 per 100 000 live births in 2010-12.
13
The report concludes, however, that scope for improvement remains, estimating that 70% of these deaths could have been avoided with better care.
Implications for clinicians and policy makers
The Global Burden of Disease study of maternal deaths worldwide reported 29 275 maternal deaths from hypertensive disorders (95% uncertainty interval, 25 664 to 33 376) in 2013, 42% (12 232) of which were in sub-Saharan Africa and 36% (10 656) in South Asia.
2 In these countries with the highest burdens and no confidential inquiry processes, there is a strong case to start inquiries to enable understanding of the specific factors implicated in maternal deaths in each setting and to make targeted recommendations. Importantly, although there may be many similarities and transferable lessons between countries, other factors may differ across healthcare systems, demographics, and income settings, highlighting the context specific nature of each inquiry process. For clinicians and policy makers considering setting up this process, good case ascertainment is a key early priority for meaningful confidential inquiries, and this may have a long latency period as a system becomes accepted and widespread among clinicians, managers, and administrative staff. In the UK it took 30 years for the inquiries to report the same number of maternal deaths as those reported to the registrar general. In this early phase, rapidly improving case ascertainment can initially increase apparent death rates, which may have contributed to the rise in death rates in the first decade of the South African confidential inquiries alongside the HIV epidemic, which contributed to increased maternal deaths at the same time.
14 Where inquiries are already established, an in-depth and integrated review of deaths, healthcare systems, and social context is necessary for pertinent lessons to be learnt and recommendations disseminated. Development and implementation of national, evidence based guidance with specific recommendations pertinent to all settings on aspirin prophylaxis, antihypertensive treatment thresholds, fluid management, and timing of delivery may be a key tool in successfully lowering maternal deaths from hypertensive disorders. But further research into the findings and recommendations of confidential inquiries in other healthcare settings should be undertaken to investigate which recommendations and strategies have been able to reduce deaths most successfully in contexts other than the UK.
In countries where maternal deaths from hypertensive disorders have become a very rare event, confidential inquiries have found that, in the majority of these cases, care could still be improved, and better care may have altered outcome. These findings, together with recent UK mortality statistics, indicate that almost complete eradication of maternal mortality from hypertensive disorders is possible. In countries where maternal mortality is low, inquiries should broaden to include associated maternal morbidity and consideration of the impact of management on perinatal mortality and other adverse fetal outcomes. Reducing the short and long term maternal and fetal complications of hypertensive disorders of pregnancy, as well as aiming for complete eradication of maternal mortality, should be the next goal. Report included 46 additional maternal deaths under heading of toxaemia of pregnancy (total n=246), however these were not included in this analysis as although these women had preeclampsia the actual cause of death was haemorrhage ('accidental haemorrhage with toxaemia' in report), in keeping with figure quoted in later reports.
1955-57, E+W As 1952-54 report.
As 1952-54 report.
Report included 17 additional maternal deaths under heading of toxaemia of pregnancy (total n=188), however these were not included in this analysis as although these women had preeclampsia the actual cause of death was haemorrhage ('accidental haemorrhage with toxaemia' in report), in keeping with figure quoted in later reports.
1958-60, E+W As 1952-54 report. Not specified.
Report included 21 additional maternal deaths under heading of toxaemia of pregnancy (total n=139), however these were not included in this analysis as although these women had preeclampsia the actual cause of death was haemorrhage ('accidental haemorrhage with toxaemia' in report), in keeping with figure quoted in later reports. Definition not specified. Classification: true (due to pregnancy or childbirth) or associated (associated with pregnancy or childbirth).
Deaths from 'toxaemia', covering eclampsia and pre-eclampsia. -
1976-78, E+W
9 th revision of ICD: Definition: Maternal death internationally defined (as per ICD-9) as death of woman whilst pregnant or within 42 days of termination of pregnancy, from any cause related to or aggravated by the pregnancy or its management, but not from accidental or incidental causes. Classification: International agreement to subdivide maternal deaths into direct (formerly true) and indirect as per ICD-9. Associated deaths split into indirect and fortuitous deaths.
9
th revision of ICD: code 642 (Hypertension complicating pregnancy, childbirth and the puerperium).
Late deaths (>42 days) excluded.
1976-80, S
Definition: All deaths during pregnancy or within 1 year of the end of pregnancy or delivery. Classification: Direct, indirect, fortuitous. Deaths from eclampsia and pre-eclampsia reported.
Original report states n=15 deaths due to hypertensive disease of pregnancy, in subsequent reports n=16 quoted. The 2003-05 enquiry reports that the latter is validated and therefore should be used, therefore n=16 used in this analysis.
2000-02, UK
10 th revision of ICD: Definition: Death of woman whilst pregnant or within 42 days of the end of pregnancy, from any cause related to or aggravated by the pregnancy or its management, but not from accidental or incidental causes. Classification: Direct, indirect, late (>42 days and <1 year post abortion, miscarriage or delivery that are due to direct or indirect causes). Coincidental (fortuitous) deaths reported separately, denoting women who died from unrelated causes which happen to occur in pregnancy or the puerperium.
Chapter renamed to: 'Pre-eclampsia and eclampsia'. Maternal deaths from pre-eclampsia and eclampsia reported. Maternal deaths from pre-eclampsia, eclampsia and acute fatty liver of pregnancy reported in 'Preeclampsia and eclampsia' chapter.
One case of AFLP not included in this analysis.
2006-08, UK As 2000-02 report.
Maternal deaths from pre-eclampsia, eclampsia and acute fatty liver of pregnancy reported in 'Preeclampsia and eclampsia' chapter. 
1955-57, E+W
'Importance of selection of cases for hospital confinement…Confusion between hospital, GP consultant, midwife and eventually "no one did anything"'.
'Vital importance of selection of cases for hospital confinement...Need for better co-operation'.
1958-60, E+W
Major 'avoidable factor': 'confusion of responsibility'.
1960-63, N.I.
Major 'avoidable factors': 'Unwise booking of high risk patients for home confinement…the lack of liaison between…services'.
'A period of treatment in hospital…only effective method…(for) anything but mildest signs of toxaemia'.
1961-63, E+W
Major 'avoidable factors': Confusion of responsibility and poor liaison…and wrong booking'.
1964-66, E+W
'Failure (GP) to seek consultant opinion and admission to hospital led to disaster on ten occasions'. 1964-67, N.I.
1967-69, E+W
'Consultant…delegated management of known difficult cases of toxaemia to inexperienced junior staff.' 'Lack of communication between family doctor and hospital '. 1965-71, S 1970-72, E+W 'Consultant sometimes at fault in delegating…cases of advanced toxaemia of pregnancy to inexperienced junior staff... but junior staff on occasions failed to request consultant help.'
1972-75, S
'The need for early recognition of pre-eclampsia and, where appropriate, referral for specialist care is as great as ever.'
1973-75, E+W
'In many cases…junior staff failed to inform the consultant in charge…procedures, such as caesarean section, were too often delegated to inexperienced junior staff.'
'It is necessary to detect the signs of hypertensive disease as early as possible and admit the patient for proper observation. All should be under supervision of a consultant obstetrician, who should play an active role in the management…and direct the team.'
1968-77, N.I.
'High risk patients should be booked for confinement in a consultant obstetric unit.' 'Patients with signs of pre-eclampsia should be referred early for consultant opinion.'
'Patients with pre-eclampsia require more frequent checks than the routine.' 'One should not fail to appreciate how rapidly pre-eclampsia can progress to eclampsia. ' 1976-78, E+W 1976-80, S 1979-81, E+W 'Suggested that in each region, an expert team(s) should be established to work in conjunction with the staff of maternity hospitals to advise about management of severe hypertension.' 'Diagnosis of…developing complications should ensure admission to hospital, skilled assessment, expert management and timely delivery.'
1982-84, E+W
'…Continuing need for expert advice and clinical assistance to be readily available.' 'Repeated measurements of blood urea, creatinine, platelets and liver enzymes are necessary to provide an early indication of…complications.' 'Combination of hypertension and significant proteinuria should lead to immediate hospital admission.'
1981-85, S
'Need for a consultant to be involved early in the management of such cases is essential. Junior medical staff should not be placed in a position to make executive clinical decisions.'
1985-87, UK
'The largest group… where care was substandard... (was) inappropriate delegation of clinical responsibility, undue delay in making or implementing critical clinical decisions.'
'Every case and at all hours, women with moderate or severe preeclampsia...be examined… by a consultant obstetrician.' 'Junior members of the obstetric team should not be permitted or expected to make executive decisions in such cases.' 'Local specialized teams should be set up in all regions.' 'Women with severe pre-eclampsia or eclampsia are best cared for in a centralized high-dependency area.' 1986-90, S 1988-90, UK "Substandard care… underlying factors were delay in taking clinical action…and failure to appreciate, often at too junior a level of clinical responsibility, the seriousness of symptoms and signs.' 'System of referral to regional centres…does not year appear to have become systematised.' 'Units must have clear policies and written protocols for clinical management of hypertensive disorders of pregnancy… particularly… use of drugs and intravenous fluids, levels of responsibility and referral for specialist advice. Junior staff should be properly versed in the procedures and encouraged to refer to their consultants at an early stage.' 'Primary response for domiciliary emergencies such as eclampsia should be by ambulance paramedics trained in cardiopulmonary resuscitation and the immediate management of obstetric complications.'
1991-93, UK
'Substandard care evident in 80%.. namely failure to take prompt action and inadequate consultant involvement. Five women developed very severe pre-eclampsia within traditional intervals between antenatal visits.'
In severe disease junior members of staff should not be decision makers. Special interest team should be developed at all units so that up to date protocols and appropriately trained staff are available.
1994-96, UK
'Substandard care…59% of cases…Underlying factors remain similar…inadequate consultant involvement and failure to take prompt action, to appreciate the severity of the disorder, to monitor the problem appropriately, to refer or transfer appropriately.'
A single senior clinician should have overall responsibility over management. Clear systems for transfer of women should be in place. Obstetrician-led special interest team should be set up in every unit. Education of medical and midwifery staff (especially community) on diagnosis, assessment and referral of preeclampsia.
1997-99, UK
'Pregnant women with a headache of sufficient severity.. or new epigastric pain...should have BP measured and urine tested for protein as a minimum' 'Clear… management protocols for severe pre-eclampsia should guide initial and continuing treatment in hospital.' 'There should be early engagement of intensive care specialists in the care of women with severe pre-eclampsia.' 'Women with moderate to severe pre-eclampsia require a level of clinical observation that may be incompatible with location in a single side room in hospital.' Guidelines for the management of severe pre-eclampsia were attached to the enquiry report.
2000-02, UK
'Clear, written, management protocols for severe pre-eclampsia should guide initial and ongoing treatment in hospital'. 'The early involvement of consultant obstetricians in the management of women with suspected or proven pre-eclampsia and eclampsia is essential.' 'There should be early engagement of intensive care specialists in the care of women with severe pre-eclampsia. 'Pregnant women with headache of sufficient severity to seek medical advice, or with new epigastric pain, should have their BP measured and urine tested for protein, as a minimum'. 1952-54, E+W 1955-57, E+W 1958-60, E+W 1960-63, N.I. 1961-63, E+W 1964-66, E+W 'Patients treated by rest in bed in the management of toxaemia of pregnancy may be more prone to develop a pulmonary embolism especially with caesarean section has been performed. ' 1964-67, N.I. 1967-69, E+W 1965-71, S 1970-72, E+W 1972-75, S 1973-75 
2003-05, UK
'As in the last report, intracranial haemorrhage was the single most common cause of death, and failure of effective antihypertensive therapy the most common source of sub-standard care.' 'The total number of deaths and the mortality rates are similar to those for the previous two triennia.. There were no deaths from pulmonary causes alone. This is consistent with the trend of recent years and is assumed to reflect better fluid management in women with pre-eclampsia.' 'Women with a systolic blood pressure of 160 mmHg or more need anti-hypertensive treatment. Consideration should be given to initiating treatment at lower pressures if the overall clinical picture suggests likely rapid deterioration with anticipation of severe hypertension.' 'Anaesthetists should anticipate an additional rise In BP at intubation in women with severe pre-eclampsia who are undergoing caesarean section under general anaesthesia and take measures to avoid a speed that compromises maternal wellbeing, even when there are concerns about fetal wellbeing. 'Syntometrine should not be given for the active management of the third stage if the mother is hypertensive, or if her BP has not been checked.' 'There has been a significant decrease in the mortality rate from hypertensive disorders of pregnancy in the period between 2009-11 and 2012-14 . This is a positive reflection on the standard and provision of care for women with hypertensive disorders of pregnancy. In this report as in previous reports, intracranial haemorrhage was the most common cause of death followed by hepatic complications. Reassuringly no women died in relation to inappropriate fluid management.'
'Keep blood pressure in all women below 150/100, with urgent treatment to achieve this in women with severe hypertension.' 'If women have a BP over 140 mmHg systolic or 90 mmHg diastolic on 2 occasions in labour or immediately after birth they should be considered for transfer to a Consultant unit.' 'Whilst intubation may be required for airway control, maternal stabilization and blood pressure control is vital prior to intubation in order to minimize maternal risk.' 'Neuroimaging should be performed urgently in any woman with hypertension or pre-eclampsia who has focal neurology or who has not recovered from a seizure.'
